OR WAIT null SECS
August 03, 2020
The investment will allow for the expansion of analytical R&D efforts and will support the company’s reference materials business.
The company has launched a residual GMP-compliant test and dual sourcing opportunity designed to increase compliance and reduce risks for ATMP manufacture.
June 25, 2020
The importance of capability and capacity of a CDMO partner to deliver drug substance and product testing should never be underestimated, considering the increasing complexity of compounds in development.
April 07, 2020
Characterizing and controlling protein aggregation is vital to ensure safety and efficacy of a biopharmaceutical product. In this interview, important aspects of protein aggregation and the tools available to address this issue are discussed.
March 02, 2020
As compounds become more complex in nature and biological ingredients are more widely used, stability testing approaches must follow suit and provide flexibility for developers.
Assays can provide a useful tool in determining the potential toxicity of drugs throughout the development cycle.
Outsourcing stability testing to full-service providers can offer comprehensive benefits to bio/pharma companies.
February 28, 2020
Eurofins DiscoverX partners with VelaLabs to enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions.
February 01, 2020
CMOs and CDMOs expanded their services and facilities in 2019 and early 2020.
January 27, 2020
Drug development contract services company PPD announces initial public offering.